Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational Results available

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

ClinicalTrials.gov ID: NCT01727154

Public ClinicalTrials.gov record NCT01727154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 6:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

Study identification

NCT ID
NCT01727154
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Dendreon
Industry
Enrollment
139 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2012 (Type not available)
Primary completion
Jul 2017 (Actual)
Completion
Jul 2017 (Actual)
Last update posted
Aug 19, 2019

2012 – 2017

United States locations

U.S. sites
39
U.S. states
25
U.S. cities
38
Facility City State ZIP Site status
21st Century Oncology Scottsdale Arizona 85251 —
Tower Urology / Tower Research Institute Los Angeles California 90048 —
Prostate Oncology Specialists, Inc. Marina del Rey California 90292 —
The Urology Center of Colorado Denver Colorado 80211 —
Howard University Cancer Center Washington D.C. District of Columbia 20060 —
First Urology, PSC Jeffersonville Indiana 47130 —
Cancer Center of Kansas Wichita Kansas 67214 —
Tulane University New Orleans Louisiana 70112 —
Highland Clinic Shreveport Louisiana 71106 —
Chesapeake Urology Research Associates Towson Maryland 21204 —
Tufts Medical Center Boston Massachusetts 02111 —
Henry Ford Health System Detroit Michigan 48202 —
Michigan Institute of Urology Troy Michigan 48084 —
St. Louis Cancer Care, LLP Bridgeton Missouri 63044 —
St. Louis Cancer Care, LLP St Louis Missouri 63127 —
Southeast Nebraska Hematology & Oncology Consultants, P.C. d/b/a Southeast Nebraska Cancer Center Lincoln Nebraska 68510 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052, 89014, 89074 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169, 89128, 98148 —
Delaware Valley Urology, LLC Mount Laurel New Jersey 08054 —
National Translational Research Group, Inc. East Setauket New York 11733 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601 —
Associated Medical Professionals of NY, PLLC Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10461 —
Carolina Urology Partners Gastonia North Carolina 28054 —
Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina Raleigh North Carolina 27607 —
TriState Urologic Services PSC Inc., dba The Urology Group Cincinnati Ohio 45212 —
Urologic Specialists of Oklahoma Tulsa Oklahoma 74146 —
Providence Health & Services Portland Oregon 97213 —
Oregon Urology Institute Springfield Oregon 97477 —
Northwest Cancer Specialists, PC Tualatin Oregon 97062 —
Urologic Consultants of SE PA Bala-Cynwyd Pennsylvania 19004 —
South Carolina Oncology Associates Columbia South Carolina 29210 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Urology Associates, P.C. Nashville Tennessee 37209 —
Texas Oncology - Fort Worth Fort Worth Texas 76104, 76132 —
Urology of Virginia, PLLC Virginia Beach Virginia 23462 —
Seattle Cancer Care Alliance Seattle Washington 98109-1023 —
University of Washington Medical Centerl Seattle Washington 98195 —
Northwest Cancer Specialists Vancouver Washington 98684, 98683 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01727154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2019 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01727154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →